It reports Thursday. Recently, it's gotten negative press over the high-handed way ABBV protected the price of Humira, their big drug that has finally lost patent protection. Will it crush gross margins? Does management have enough to offset that loss? If management addresses this issue, shares could go down.
It reports Thursday. There's so much competition now, and Paypal margins are shrinking. They laid off 2,000 or 7% of staff earlier this week to cut costs. You don't do if you feel good about your earnings. BTW, the fastest part of Apple Services includes payments; who needs PayPal when Apple payments are built into your phone?
A UK online luxury clothier with only 21% of sales from the US. They sell a few brands from their platform, and have a stake in a company that is an online luxury retailer boasting super-fast delivery--a great company. Problem is FTCH is losing a ton of money and lacks a path to profits. New growth is impressive though. Only 2021 was profitable in terms of EBITDA (during Covid lockdowns). Shares have plunged since then and they recently offered disappointing long-term guidance. Share sank 35% in one day. It has recovered to some degree, though.
It reports Wednesday. Why is it a dog? It isn't the company, but rather it's suffering the Covid hangover--it's suffering bad YOY comps and last year was Covid. A bigger question is whether they can afford more staff? Another woe is theft.